Sonic Healthcare (OTCMKTS:SKHHY) Sees Strong Trading Volume - Should You Buy?

Key Points

• Sonic Healthcare (OTCMKTS:SKHHY) ADR experienced unusually high trading volume on Friday — about 133,298 shares, a 35% increase from the prior session — and last traded at $15.0220 versus the previous close of $14.62.
• Analyst sentiment is negative: Citigroup downgraded the stock from "hold" to "strong sell", and MarketBeat shows a consensus "Sell" rating.
• The ADR is trading near its technical averages, with a 50-day simple moving average of $15.10 and a 200-day simple moving average of $14.93.

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY - Get Free Report) saw unusually-high trading volume on Friday . Approximately 133,298 shares traded hands during mid-day trading, an increase of 35% from the previous session's volume of 99,004 shares.The stock last traded at $15.0220 and had previously closed at $14.62.

Analyst Ratings Changes

Separately, Citigroup lowered Sonic Healthcare from a "hold" rating to a "strong sell" rating in a report on Monday, January 26th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of "Sell".

Sonic Healthcare Price Performance

The company has a fifty day simple moving average of $15.10 and a two-hundred day simple moving average of $14.93.

Sonic Healthcare Company Profile

Sonic Healthcare OTCMKTS: SKHHY is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.

The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.